Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland.
Neurosurgery. 2012 Jun;70(6):1504-18; discussion 1518-9. doi: 10.1227/NEU.0b013e31824a36e8.
Various surgical approaches for the removal of tuberculum sellae meningiomas (TSMs) have previously been described.
To assess the reliability and safety of the lateral supraorbital (LSO) approach to remove TSMs.
We identified all TSM patients operated on at the Department of Neurosurgery at Helsinki University Central Hospital, Finland, by the senior author (J.H.) using the LSO approach between September 1997 and August 2010. We retrospectively analyzed the clinical data, radiological findings, surgical treatment, histology, and outcome of patients and discuss the operative technique.
Apparent complete tumor removal was achieved in 45 patients (87%). Of 42 patients, preexisting visual deficit improved in 22, remained the same in 13, and worsened in 7, and de novo visual deficit occurred in 1 patient. At 3 months post-discharge, 47 patients (90%) had a good recovery, 4 (8%) were moderately disabled, and 1 (2%) died 40 days after surgery of unexplained cardiac arrest. Seven patients (13%) had minimal residual tumors, 2 of which required reoperation. During the median follow-up of 59 months (range, 1-133 months), tumor recurred in 1 of the patients who had undergone a second operation.
TSMs of all sizes can be removed via the LSO approach with minimal morbidity and mortality. Low-power or no coagulation is recommended near the optic nerves and the optic chiasm to preserve their vascular support from the internal carotid artery perforators. Our results are comparable to those obtained using more extensive and time-consuming approaches. We recommend the LSO approach to remove TSMs.
先前已经描述过各种用于切除鞍结节脑膜瘤(TSM)的手术方法。
评估经外侧眶上(LSO)入路切除 TSM 的可靠性和安全性。
我们通过高级作者(J.H.)在芬兰赫尔辛基大学中心医院神经外科使用 LSO 入路对 1997 年 9 月至 2010 年 8 月间接受手术的所有 TSM 患者进行了识别。我们回顾性地分析了患者的临床数据、影像学发现、手术治疗、组织学和结果,并讨论了手术技术。
在 45 例患者(87%)中实现了明显的肿瘤完全切除。在 42 例患者中,术前存在的视力障碍在 22 例中得到改善,在 13 例中保持不变,在 7 例中恶化,1 例出现新的视力障碍。出院后 3 个月,47 例(90%)患者恢复良好,4 例(8%)中度残疾,1 例(2%)术后 40 天因不明原因心脏骤停死亡。7 例(13%)患者有微小残留肿瘤,其中 2 例需要再次手术。在中位数为 59 个月(范围 1-133 个月)的随访期间,1 例接受第二次手术的患者肿瘤复发。
通过 LSO 入路可以切除所有大小的 TSM,且发病率和死亡率都很低。建议在视神经和视交叉附近使用低功率或无电凝,以保留来自颈内动脉穿支的血管支持。我们的结果与使用更广泛和耗时的方法获得的结果相当。我们建议采用 LSO 入路切除 TSM。